Performance of Xpert

dc.contributor.affiliationCenters for Disease Control and Prevention, Atlanta, GA, USA.
dc.contributor.affiliationMinistry of Health Zambia National TB Programme, Lusaka, Zambia.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
dc.contributor.affiliationUniversity of Alabama at Birmingham, Birmingham, AL, USA.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorKasaro MP
dc.contributor.authorChilyabanyama ON
dc.contributor.authorShah NS
dc.contributor.authorMuluka B
dc.contributor.authorKapata N
dc.contributor.authorKrüüner A
dc.contributor.authorMwaba I
dc.contributor.authorKaunda K
dc.contributor.authorCoggin WL
dc.contributor.authorWen XJ
dc.contributor.authorHenostroza G
dc.contributor.authorReid S
dc.date.accessioned2025-05-23T11:41:03Z
dc.date.issued2020-Dec-21
dc.description.abstractSETTING: Peri-urban health facilities providing HIV and TB care in Zambia. OBJECTIVE: To evaluate 1) the impact of Xpert DESIGN: Quasi-experimental study design with the first cohort evaluated per standard-of-care (SOC; first sputum tested using smear microscopy) and the second cohort per an algorithm using Xpert as initial test (intervention phase; IP). Xpert testing was provided onsite in Chongwe District, while samples were transported 5-10 km in Kafue District. TB was confirmed using mycobacterial culture. RESULTS: Among 1350 PLHIV enrolled, 156 (15.4%) had confirmed TB. Time from TB evaluation to diagnosis ( CONCLUSION: Xpert improved time to diagnosis and treatment initiation, but there was no difference in all-cause mortality. High sensitivity of Determine TB-LAM Ag at lower CD4 count supports increased use in settings providing care to PLHIV, particularly with advanced HIV disease.
dc.identifier.doi10.5588/pha.20.0010
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10381
dc.sourcePublic health action
dc.titlePerformance of Xpert

Files

Collections